Sai Parenterals Limited IPO
Listed · Mainboard · BSE, NSE
Last updated: · Compiled by IPONOVA Editorial Desk · How we source data
IPO Details
| Price Band | ₹372.00–₹392.00 |
|---|---|
| Lot Size | 38 shares |
| Issue Size | ₹409cr |
| Open Date | 24 Mar 26 |
| Close Date | 27 Mar 26 |
| Listing Date | 02 Apr 26 |
| Exchange | BSE, NSE |
| Subscription | 1.08x |
About Sai Parenterals Limited
Sai Parenteral’s Limited is a diversified pharmaceutical formulations company incorporated in January 2001. It was originally established as a private limited company and was converted into a public limited company in January 2022. Anil Kumar Karusala, Vijitha Gorrepati and Karusala Aruna promote the Company. The Company operates across branded generic formulations and contract development and manufacturing (CDMO) services. Its product portfolio spans multiple therapeutic areas, including cardiovascular, neuropsychiatry, anti-diabetic, antibiotics, gastroenterology, respiratory care, dermatology, and vitamins and supplements. Offerings cover a wide range of dosage forms such as injectables, tablets, capsules, liquid orals and ointments. Sai Parenteral has strong capabilities in sterile injectable manufacturing, including dry powder injections, vials, ampoules and pre-filled syringes. Its operations are supported by multiple manufacturing facilities in Telangana and Andhra Pradesh, along with in-house research and development capabilities. The Company follows an integrated business model, combining product development, manufacturing and customer-centric execution. Its key strengths include diversified product offerings, established manufacturing infrastructure, regulatory-focused processes and long-standing promoter-led management experience. Discuss on Trading Q&A
Anchor Investor Allotment
| Anchor Investor Name | Eq. Shares | Allocation % | Bid Price | Investment Amount | 30-Day Lock-in | 90-Day Lock-in |
|---|---|---|---|---|---|---|
| Quant Mutual Fund - Quant Momentum Fund | 918,384 | 29.36% | ₹392.00 | ₹36.00 Cr | 15 May 2026 | 11 Aug 2026 |
| Kotak Mahindra Life Insurance Company Ltd | 765,320 | 24.46% | ₹392.00 | ₹30.00 Cr | 15 May 2026 | 11 Aug 2026 |
| Kotak Life Sciences Fund I | 765,282 | 24.46% | ₹392.00 | ₹30.00 Cr | 15 May 2026 | 11 Aug 2026 |
| Morgan Stanley Asia (Singapore) Pte. | 382,650 | 12.23% | ₹392.00 | ₹15.00 Cr | 15 May 2026 | 11 Aug 2026 |
| India Emerging Giants Fund Limited | 296,849 | 9.49% | ₹392.00 | ₹11.64 Cr | 15 May 2026 | 11 Aug 2026 |
| TOTAL (5 investors) | 3,128,485 | 100.00% | ₹122.64 Cr | |||
Lock-in dates calculated from allotment date (30 & 90 calendar days, adjusted to next NSE trading day as per exchange holiday calendar).
For live subscription data, allotment status and full IPO analysis, visit IPONOVA — India's IPO Intelligence Platform.
Frequently Asked Questions
- When does the Sai Parenterals Limited IPO open and close?
- The Sai Parenterals Limited IPO opens for subscription on 24 Mar 26. It closes on 27 Mar 26.
- What is the price band of Sai Parenterals Limited IPO?
- The price band of Sai Parenterals Limited IPO is ₹372.00 to ₹392.00 per share.
- What is the minimum lot size for Sai Parenterals Limited IPO?
- The minimum lot size for Sai Parenterals Limited IPO is 38 shares, requiring a minimum investment of ₹14,896.
- When will Sai Parenterals Limited list on stock exchanges?
- Sai Parenterals Limited is expected to list on BSE, NSE on 02 Apr 26.
- How can I check Sai Parenterals Limited IPO allotment status?
- You can check Sai Parenterals Limited IPO allotment status on IPONOVA after the basis of allotment is finalized, or via the registrar's website using your PAN number, application number, or DP/Client ID.
- How to apply for Sai Parenterals Limited IPO?
- You can apply for Sai Parenterals Limited IPO through your broker's app (Zerodha, Groww, Upstox, etc.) or via UPI-enabled net banking using ASBA. Submit the application during the IPO subscription window with the price within the band ₹372.00 to ₹392.00 per share.
Data Sources & Verification
This page aggregates publicly available data for the Sai Parenterals Limited IPO from the following authoritative sources:
- SEBI — Red Herring Prospectus (RHP) and regulatory filings · sebi.gov.in
- BSE Limited — Issue circulars, subscription data, listing notices · bseindia.com
- National Stock Exchange of India (NSE) — Public issue data, listing data · nseindia.com
- Registrar to the Issue — Allotment status (Link Intime, KFin Technologies, Bigshare Services, MUFG Intime)
Subscription, allotment and listing data is refreshed throughout each IPO's issue window directly from the exchanges and registrars listed above. Always read the official offer document (RHP) before applying. For corrections, contact IPONOVA Editorial Desk.